-
Side effects from these common drugs could lead to unnecessary additional prescriptions: study
Medical Mythbusting Commentary for October 2, 2026 Source:Side effects from these common drugs could lead to unnecessary additional prescriptions: study Reference:Exploring high priority potentially inappropriate prescribing cascades in older adults: population level retrospective cohort study
-
New approach to treating metastatic pancreatic adenocarcinoma for people who already had at least one systemic treatment, or who cannot take multi-drug chemotherapy.
Medical Mythbusting Commentary for October 1, 2026 Source:This Pill Will Change Cancer Treatment Forever Reference:Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer,
-
Study finds no causal link between prenatal paracetamol and neurodevelopmental disorders
Medical Mythbusting Commentary for September 25, 2026 Source:Study finds no causal link between prenatal paracetamol and neurodevelopmental disorders Reference:Prenatal exposure to paracetamol and the risk of autism and attention‐deficit/hyperactivity disorder: An umbrella review and meta‐meta‐analysis.
-
This upcoming season’s COVID vaccine recommendations
Medical Mythbusting Commentary for September 14, 2026 Source:The Newest COVID Shot Is Here — Doctors Suggest The Best Time To Get It For The Most Protection
-
Most hair loss associated with GLP1-agonist medications is due to telogen effluvium. It is the rapid weight loss not the drug in this instance that leads to temporary hair loss.
Medical Mythbusting Commentary for September 9, 2026 Source:Could Your GLP-1 Be Making You Bald? One Study Says Maybe Reference:A causal effect of increased GLP1R expression on male-pattern hair loss is suggested by 2-sample Mendelian randomization
-
Mass testosterone screening of healthy male military personnel is not based on clinical evidence or guidelines and is unlikely to change battle readiness or health outcomes.
Medical Mythbusting Commentary for September , 2026 Source:Pentagon issues clinical guidelines on troop testosterone screening to start immediately Reference:The CTV piece is a Reuters write-up of Defense Health Agency clinical guidance issued 2 September 2026. That guidance implements Secretary Hegseth’s 15 July 2026 memo requiring mandatory testosterone-deficiency screening for all active-duty and reserve members aged…
-
Newer GLP-1 medications may reduce alcohol-related hospitalization risk
Medical Mythbusting Commentary for July 23, 2026 Source:Newer GLP-1 medications may reduce alcohol-related hospitalization risk Reference:Association between GLP-1 receptor agonists and alcohol-related hospitalisations among adults with alcohol use disorder: multi-target trial emulation study.
-
A new treatment for pancreatic cancer has been developed that on average increases survival from from six months to 12 but Canadians don’t have access to it. Here’s why.
Medical Mythbusting Commentary for July 15, 2026 Source:A new cancer treatment is hailed as a breakthrough, but Canadians don’t have access to it. Here’s why.
-
An antipsychotic medication quetiapine used off-label as a sleep aid can affect sleep quality and concentration in untreated sleep apnea patients.
Medical Mythbusting Commentary for June 23, 2026 Source:A Commonly Used Sleep Aid May Have a Dangerous Side Effect Reference:Quetiapine modestly improves sleep and breathing but impairs next day performance in people with OSA and difficulty maintaining sleep: A randomized controlled trial